{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:22:24Z","timestamp":1769599344333,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T00:00:00Z","timestamp":1471996800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s40272-016-0187-z","type":"journal-article","created":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T06:02:37Z","timestamp":1472018557000},"page":"379-385","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The Cognitive Profile of Ethosuximide in Children"],"prefix":"10.1007","volume":"18","author":[{"given":"Dominique M.","family":"IJff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamar M.","family":"van Veenendaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariette H.","family":"Debeij-van Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacobus F. A.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton J. A.","family":"de Louw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian H. J. M.","family":"Majoie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert P.","family":"Aldenkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,24]]},"reference":[{"key":"187_CR1","first-page":"317","volume":"12","author":"EB Posner","year":"2013","unstructured":"Posner EB. Absence seizures in children. BMJ Clin Evid. 2013;12:317\u2013332.","journal-title":"BMJ Clin Evid"},{"key":"187_CR2","doi-asserted-by":"crossref","unstructured":"Caraballo RH, Dalla Bernadina B. Idiopathic generalized epilepsies. In: Dulac O, Lassonde M, Sarnat HB, editors. Handbook of clinical neurology. Oxford: Elsevier Science; 2013. p. 579\u201389.","DOI":"10.1016\/B978-0-444-52891-9.00060-9"},{"key":"187_CR3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/epi.12074","volume":"54","author":"TA Glauser","year":"2013","unstructured":"Glauser TA, Ben-Menachem E, Bourgeois B, et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2013;54:551\u201363.","journal-title":"Epilepsia"},{"key":"187_CR4","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1212\/WNL.0000000000001971","volume":"85","author":"S Shinnar","year":"2015","unstructured":"Shinnar S, Cnaan A, Hu F, et al. Long-term outcomes of generalized tonic-clonic seizures in a childhood absence epilepsy trial. Neurology. 2015;85:1108\u201314.","journal-title":"Neurology"},{"key":"187_CR5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1528-1167.2005.00326.x","volume":"46","author":"PN Patsalos","year":"2005","unstructured":"Patsalos PN. Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies. Epilepsia. 2005;46:140\u20138.","journal-title":"Epilepsia"},{"key":"187_CR6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1212\/WNL.8.10.769","volume":"8","author":"FT Zimmerman","year":"1958","unstructured":"Zimmerman FT, Burgemeister BB. A new drug for petit mal epilepsy. Neurology. 1958;8:769\u201375.","journal-title":"Neurology."},{"key":"187_CR7","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1469-8749.1982.tb13703.x","volume":"24","author":"N Callaghan","year":"1982","unstructured":"Callaghan N, Ohara J, Odriscoll D, et al. Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petitmal). Dev Med Child Neurol. 1982;24:830\u20136.","journal-title":"Dev Med Child Neurol"},{"key":"187_CR8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1212\/WNL.32.2.157","volume":"32","author":"S Sato","year":"1982","unstructured":"Sato S, White BG, Penry JK, et al. Valproic acid versus ethosuximide in the treatment of absence seizures. Neurology. 1982;32:157\u201363.","journal-title":"Neurology"},{"key":"187_CR9","first-page":"301","volume-title":"Advances in epileptology, XIVth epilepsy international symposium","author":"Z Martinovic","year":"1983","unstructured":"Martinovic Z. Comparison of ethosuximide with sodium valproate. In: Parsonage M, Grant R, Craig Jr AW, editors. Advances in epileptology, XIVth epilepsy international symposium. New York: Raven Press; 1983. p. 301\u20135."},{"key":"187_CR10","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa0902014","volume":"362","author":"TA Glauser","year":"2010","unstructured":"Glauser TA, Cnaan A, Shinnar S, et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med. 2010;362:790\u20139.","journal-title":"N Engl J Med"},{"key":"187_CR11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/epi.12028","volume":"54","author":"TA Glauser","year":"2013","unstructured":"Glauser TA, Cnaan A, Shinnar S, et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months. Epilepsia. 2013;54:141\u201355.","journal-title":"Epilepsia"},{"key":"187_CR12","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1212\/WNL.0b013e3182a9f3ca","volume":"81","author":"D Masur","year":"2013","unstructured":"Masur D, Shinnar S, Cnaan A, et al. Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsy. Neurology. 2013;81:1572\u201380.","journal-title":"Neurology"},{"key":"187_CR13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.yebeh.2009.08.002","volume":"16","author":"DE Mandelbaum","year":"2009","unstructured":"Mandelbaum DE, Burack GD, Bhise VV. Impact of antiepileptic drugs on cognition, behavior, and motor skills in children with new-onset, idiopathic epilepsy. Epilepsy Behav. 2009;16:341\u20134.","journal-title":"Epilepsy Behav"},{"issue":"2","key":"187_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/ane.12517","volume":"134","author":"E Grevers","year":"2016","unstructured":"Grevers E, Breuer LEM, IJff DM, et al. Mental slowing in relation to epilepsy and antiepileptic medication. Acta Neurol Scand. 2016;134(2):116\u201322. doi: 10.1111\/ane.12517 .","journal-title":"Acta Neurol Scand."},{"key":"187_CR15","unstructured":"IJff DM, Aldenkamp AP. Comorbidities of treatment with antiepileptic drugs. In: Duchowny M, Cross JH, Arzimanoglou A, editors. Pediatric epilepsy. New York: McGraw-Hill Professional; 2012. p. 424\u201336."},{"key":"187_CR16","volume-title":"Wechsler Intelligence Scale for Children derde editie NL, Handleiding en verantwoording","author":"D Wechsler","year":"2005","unstructured":"Wechsler D. Wechsler Intelligence Scale for Children derde editie NL, Handleiding en verantwoording. Amsterdam: Harcourt Test Publishers; 2005."},{"key":"187_CR17","volume-title":"The Beery-Buktenica developmental test of visual-motor integration, administration, scoring and teaching manual","author":"KE Beery","year":"2006","unstructured":"Beery KE, Beery NA. The Beery-Buktenica developmental test of visual-motor integration, administration, scoring and teaching manual. 5th ed. Minneapolis: NCS Pearson; 2006.","edition":"5"},{"key":"187_CR18","volume-title":"De 15-woorden tests A en B : (een voorlopige handleiding) (15WT\/VWT)","author":"AF Kalverboer","year":"1986","unstructured":"Kalverboer AF, Deelman BG. De 15-woorden tests A en B : (een voorlopige handleiding) (15WT\/VWT). Groningen: Academisch Ziekenhuis Groningen, afd. Neuropsychologie; 1986."},{"key":"187_CR19","volume-title":"FePsy: \u2018The Iron Psyche\u2019","author":"WCJ Alpherts","year":"1995","unstructured":"Alpherts WCJ, Aldenkamp AP. FePsy: \u2018The Iron Psyche\u2019. Heemstede: Instituut voor epilepsiebestrijding; 1995."},{"key":"187_CR20","unstructured":"Vos PG. Bourdon-Vos test handleiding. Swetss test services; 1988."},{"key":"187_CR21","volume-title":"Test of Everyday Attention in Children","author":"T Manly","year":"2004","unstructured":"Manly T, Robertson I, Anderson V, et al. Test of Everyday Attention in Children. Amsterdam: Pearson; 2004."},{"key":"187_CR22","doi-asserted-by":"crossref","unstructured":"IJff DM, Aldenkamp AP. Cognitive side-effects of antiepileptic drugs in children. In: Dulac O, Lassonde M, Sarnat HB, editors. Handbook of clinical neurology. Oxford: Elsevier Science; 2013. p. 707\u201318.","DOI":"10.1016\/B978-0-444-52891-9.00073-7"},{"key":"187_CR23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1212\/01.wnl.0000230138.46508.5b","volume":"67","author":"F Donati","year":"2006","unstructured":"Donati F, Gobbi G, Campistol J, et al. Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures. Neurology. 2006;67:679\u201382.","journal-title":"Neurology"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-016-0187-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-016-0187-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-016-0187-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T21:15:52Z","timestamp":1498338952000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-016-0187-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,24]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["187"],"URL":"https:\/\/doi.org\/10.1007\/s40272-016-0187-z","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,24]]}}}